Duties and Responsibilities :
- Establish Company as a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies that target p53 mutations.
- Maintain clinical, scientific, and technical expertise in relevant Oncology therapies and treatment areas.
- Collaborate with Medical Affairs, Clinical Operations, and other relevant internal stakeholders, and serve as a Company resource to external stakeholders.
- Collaborate with the clinical sites to enhance activities related to patient identification and enrollment into clinical trial.
Activities include identifying drivers and barriers to patient identification and enrollment; identifying patient journey / pathway through the clinical site and working with identified departments / referral centers to raise awareness of clinical trial and potential of patient inclusion.
Engage with investigators and site staff to ensure awareness of Company’s clinical trial is maintained at a prominent level and is differentiated from competing protocols;
and that they are familiar with all protocol and patient information.
- Provide the investigators and site staff with relevant, compliant, and consistent medical and scientific support and communications.
- Develop and track KOL engagement plans identify, develop, and maintain collaborative relationships with KOLs within assigned region.
Participate in medical and scientific exchanges with the medical / scientific community.
- Facilitate research collaborations (including Investigator-Supported Trials) with key investigators by helping to identify, establish, and maintain such collaborations.
- Engage in speaker identification, training and evaluation and provide support for advisory board meetings as requested.
- Collaborate with Market Access and Commercial colleagues for thought leader and institutional engagement where appropriate.
Qualifications :
- Advanced terminal degree strongly preferred (PharmD, PhD, DNP or MD). Will consider NP, MSN, or PA with Oncology and MSL experience.
- Minimum of 3+ years previous oncology MSL experience required (Breast, GYN, lung preferred)
- Minimum of 5+ years of clinical and / or research experience in Oncology required.
- Fluency in at least one commonly spoken European language in addition to English strongly preferred.
- A working knowledge of ICH / GCP.
- Established relationships with Oncology KOLs and stakeholders at both academic institutions and community practices preferred.
- Ability to travel, locally and regionally, up to 60% with overnight stays (e.g., KOL meetings, site locations, internal meetings / trainings, medical congresses) required.
- Experience collaborating with payers of formulary committees preferred.
- Knowledge of FDA requirements and PhRMA Code, including regulations governing compliant scientific exchange required.
- Demonstrated project management ability required.
- Excellent communication (oral and written) and people skills required.
- Valid driver’s license
Salary offers to be determined based on industry experience, education and therapeutic expertise.